Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.8, Iss.5, 2010-09, pp. : 301-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Healthcare reforms and cost reduction strategies in Europe: The cases of Germany, UK, Switzerland, Italy and France

By Simonet Daniel

International Journal of Health Care Quality Assurance, Vol. 23, Iss. 5, 2010-01 ,pp. : 470-488

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Drugs for Rare Diseases: Influence of Orphan Designation Status on Price

By Picavet Eline

Applied Health Economics and Health Policy, Vol. 9, Iss. 4, 2011-07 ,pp. : 275-279

Adis International

Access to resources Recommend Favorite

Iodine deficiency in 2007: Global progress since 2003

By de Benoist Bruno McLean Erin Andersson Maria Rogers Lisa

Food & Nutrition Bulletin, Vol. 29, Iss. 3, 2008-09 ,pp. : 195-202

Nevin Scrimshaw International Nutrition Foundation

Access to resources Recommend Favorite

Spicing Up the Imagination: Culinary Exoticism in France and Germany, 1930-1990

By Régnier Faustine

Food and Foodways, Vol. 11, Iss. 4, 2003-10 ,pp. : 189-214

Routledge Ltd

Access to resources Recommend Favorite

Hepatitis A and B in children and adolescents - what can we learn from Puglia (Italy) and Catalonia (Spain)?

By Lopalco

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 470-474

Elsevier

Access to resources Recommend Favorite